Long Covid19: Clinical Trials

4 trials for Long Covid19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow Long Covid19: new trials by email Literature Review of Long Covid19 trials Research Report on Long Covid19

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)
Ivabradine, Ivabradine Placebo, Coordinated Care - Long COVID, Long Covid19
Phase 2CompletedKanecia Obie Zimmerman1812024-03-112026-02-20
RECOVER-AUTONOMIC Platform Protocol
IVIG + Coordinated Care, IVIG Placebo + Coordinated Care, Ivabradine + Coordinated Care - Long COVID, Long Covid19
Phase 2CompletedKanecia Obie Zimmerman3812024-03-112026-08-03
RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms
Experimental: Paxlovid 25 day dosing, Experimental: Paxlovid 15 day dosing, Placebo Comparator: Control - Long COVID, Long Covid19
Phase 2CompletedKanecia Obie Zimmerman9632023-07-262025-12-02
ImPROving Quality of LIFe in the Long COVID Patient
Nirmatrelvir/ritonavir, Placebo/ritonavir - Post-COVID-19 Syndrome, Long COVID
Phase 2CompletedKarolinska Institutet2192023-05-012024-12-04

Narrower conditions

Post-Acute COVID-19 Syndrome (4)  ·  COVID-19 (1)  ·  Post-Infectious Disorders (1)  ·  Postural Orthostatic Tachycardia Syndrome (1)

Broader conditions

Chronic Disease (4)  ·  Coronaviridae Infections (4)  ·  Coronavirus Infections (4)  ·  Disease Attributes (4)  ·  Infections (4)  ·  Lung Diseases (4)  ·  Nidovirales Infections (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Pneumonia (4)  ·  Pneumonia, Viral (4)  ·  RNA Virus Infections (4)  ·  Respiratory Tract Diseases (4)  ·  Respiratory Tract Infections (4)  ·  Virus Diseases (4)

Interventions

Ivabradine (2)  ·  Immunoglobulins, Intravenous (1)  ·  Ritonavir (1)  ·  nirmatrelvir and ritonavir drug combination (1)

Sponsors

Kanecia Obie Zimmerman (3)  ·  Karolinska Institutet (1)

Countries

United States (3)  ·  Puerto Rico (1)  ·  Sweden (1)

Top investigators

Cyndya Shibao, MD (2)  ·  Pam Taub, MD (2)  ·  Peter Novak, MD (2)  ·  Tae Chung, MD (2)  ·  Christopher Grainger, MD (1)  ·  Christopher Granger, MD (1)  ·  Kanecia Zimmerman, MD PhD (1)  ·  Michael Runold, MD, PhD (1)  ·  Richard Whitley, MD (1)

Results publications

PMID 41720282, PMID 42673984